nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—ABCC1—Rifampicin—leprosy	0.291	0.349	CbGbCtD
Mitoxantrone—CYP2E1—Thalidomide—leprosy	0.143	0.172	CbGbCtD
Mitoxantrone—CYP2E1—Rifampicin—leprosy	0.139	0.166	CbGbCtD
Mitoxantrone—CYP2E1—Dapsone—leprosy	0.115	0.137	CbGbCtD
Mitoxantrone—ABCB1—Rifampicin—leprosy	0.0702	0.0841	CbGbCtD
Mitoxantrone—CYP3A4—Rifampicin—leprosy	0.0421	0.0504	CbGbCtD
Mitoxantrone—CYP3A4—Dapsone—leprosy	0.0347	0.0416	CbGbCtD
Mitoxantrone—Myelodysplastic syndrome—Thalidomide—leprosy	0.00787	0.0584	CcSEcCtD
Mitoxantrone—Tumour lysis syndrome—Thalidomide—leprosy	0.00569	0.0422	CcSEcCtD
Mitoxantrone—Fungal skin infection—Thalidomide—leprosy	0.00378	0.0281	CcSEcCtD
Mitoxantrone—TOP2A—Menadione—Thalidomide—leprosy	0.00362	1	CbGdCrCtD
Mitoxantrone—Proteinuria—Dapsone—leprosy	0.00351	0.0261	CcSEcCtD
Mitoxantrone—Protein urine present—Dapsone—leprosy	0.00346	0.0257	CcSEcCtD
Mitoxantrone—Sinus bradycardia—Thalidomide—leprosy	0.00322	0.0239	CcSEcCtD
Mitoxantrone—White blood cell count decreased—Thalidomide—leprosy	0.00318	0.0236	CcSEcCtD
Mitoxantrone—Platelet count decreased—Thalidomide—leprosy	0.00266	0.0197	CcSEcCtD
Mitoxantrone—Febrile neutropenia—Thalidomide—leprosy	0.00263	0.0195	CcSEcCtD
Mitoxantrone—Serum creatinine increased—Thalidomide—leprosy	0.00257	0.0191	CcSEcCtD
Mitoxantrone—Menstrual disorder—Thalidomide—leprosy	0.00232	0.0172	CcSEcCtD
Mitoxantrone—SLC47A2—tendon—leprosy	0.00228	0.0843	CbGeAlD
Mitoxantrone—PIM1—eye—leprosy	0.00225	0.0832	CbGeAlD
Mitoxantrone—Interstitial lung disease—Thalidomide—leprosy	0.00223	0.0166	CcSEcCtD
Mitoxantrone—Myocardial ischaemia—Thalidomide—leprosy	0.00197	0.0146	CcSEcCtD
Mitoxantrone—PIM1—skin of body—leprosy	0.00196	0.0723	CbGeAlD
Mitoxantrone—Petechiae—Thalidomide—leprosy	0.00192	0.0143	CcSEcCtD
Mitoxantrone—SLC47A2—nervous system—leprosy	0.00186	0.0685	CbGeAlD
Mitoxantrone—Amenorrhoea—Thalidomide—leprosy	0.0018	0.0133	CcSEcCtD
Mitoxantrone—Proteinuria—Thalidomide—leprosy	0.0018	0.0133	CcSEcCtD
Mitoxantrone—Protein urine present—Thalidomide—leprosy	0.00177	0.0132	CcSEcCtD
Mitoxantrone—Viral infection—Thalidomide—leprosy	0.00175	0.013	CcSEcCtD
Mitoxantrone—Hypocalcaemia—Thalidomide—leprosy	0.00173	0.0128	CcSEcCtD
Mitoxantrone—BTK—tendon—leprosy	0.00172	0.0636	CbGeAlD
Mitoxantrone—Hyperuricaemia—Thalidomide—leprosy	0.0017	0.0126	CcSEcCtD
Mitoxantrone—Bone pain—Thalidomide—leprosy	0.00165	0.0122	CcSEcCtD
Mitoxantrone—Sinusitis—Dapsone—leprosy	0.00162	0.012	CcSEcCtD
Mitoxantrone—Blood uric acid increased—Thalidomide—leprosy	0.00161	0.0119	CcSEcCtD
Mitoxantrone—Hyperkalaemia—Thalidomide—leprosy	0.00155	0.0115	CcSEcCtD
Mitoxantrone—Pharyngitis—Dapsone—leprosy	0.00154	0.0114	CcSEcCtD
Mitoxantrone—Blood urea increased—Thalidomide—leprosy	0.00149	0.0111	CcSEcCtD
Mitoxantrone—PIM1—tendon—leprosy	0.00149	0.0551	CbGeAlD
Mitoxantrone—BTK—testis—leprosy	0.00143	0.0526	CbGeAlD
Mitoxantrone—Sepsis—Thalidomide—leprosy	0.00137	0.0102	CcSEcCtD
Mitoxantrone—Erythema—Dapsone—leprosy	0.00135	0.01	CcSEcCtD
Mitoxantrone—Vision blurred—Dapsone—leprosy	0.00127	0.00944	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Thalidomide—leprosy	0.00126	0.00939	CcSEcCtD
Mitoxantrone—Renal failure acute—Thalidomide—leprosy	0.00124	0.00922	CcSEcCtD
Mitoxantrone—PIM1—testis—leprosy	0.00123	0.0456	CbGeAlD
Mitoxantrone—PIM1—nervous system—leprosy	0.00121	0.0448	CbGeAlD
Mitoxantrone—SLC47A1—eye—leprosy	0.00121	0.0446	CbGeAlD
Mitoxantrone—Cough—Dapsone—leprosy	0.00118	0.00874	CcSEcCtD
Mitoxantrone—Cardiac failure—Thalidomide—leprosy	0.00118	0.00872	CcSEcCtD
Mitoxantrone—Hyponatraemia—Thalidomide—leprosy	0.00115	0.00855	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00115	0.00851	CcSEcCtD
Mitoxantrone—Tachycardia—Dapsone—leprosy	0.00107	0.00798	CcSEcCtD
Mitoxantrone—Blood creatinine increased—Thalidomide—leprosy	0.00107	0.00797	CcSEcCtD
Mitoxantrone—Dehydration—Thalidomide—leprosy	0.00107	0.00792	CcSEcCtD
Mitoxantrone—Hypokalaemia—Thalidomide—leprosy	0.00104	0.00775	CcSEcCtD
Mitoxantrone—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00103	0.00767	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Thalidomide—leprosy	0.00101	0.00751	CcSEcCtD
Mitoxantrone—Pancytopenia—Thalidomide—leprosy	0.000941	0.00699	CcSEcCtD
Mitoxantrone—Neutropenia—Thalidomide—leprosy	0.000927	0.00688	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Thalidomide—leprosy	0.000921	0.00684	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Thalidomide—leprosy	0.000913	0.00678	CcSEcCtD
Mitoxantrone—Weight increased—Thalidomide—leprosy	0.000902	0.0067	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Dapsone—leprosy	0.0009	0.00668	CcSEcCtD
Mitoxantrone—Weight decreased—Thalidomide—leprosy	0.000897	0.00666	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Thalidomide—leprosy	0.000894	0.00664	CcSEcCtD
Mitoxantrone—Pneumonia—Thalidomide—leprosy	0.000889	0.0066	CcSEcCtD
Mitoxantrone—CYP1B1—eye—leprosy	0.000884	0.0327	CbGeAlD
Mitoxantrone—Drowsiness—Thalidomide—leprosy	0.000884	0.00656	CcSEcCtD
Mitoxantrone—TOP2A—tendon—leprosy	0.000875	0.0323	CbGeAlD
Mitoxantrone—Acute coronary syndrome—Thalidomide—leprosy	0.000871	0.00647	CcSEcCtD
Mitoxantrone—Body temperature increased—Dapsone—leprosy	0.00087	0.00646	CcSEcCtD
Mitoxantrone—Abdominal pain—Dapsone—leprosy	0.00087	0.00646	CcSEcCtD
Mitoxantrone—Renal failure—Thalidomide—leprosy	0.000869	0.00645	CcSEcCtD
Mitoxantrone—Myocardial infarction—Thalidomide—leprosy	0.000866	0.00643	CcSEcCtD
Mitoxantrone—Stomatitis—Thalidomide—leprosy	0.000861	0.00639	CcSEcCtD
Mitoxantrone—Conjunctivitis—Thalidomide—leprosy	0.000859	0.00638	CcSEcCtD
Mitoxantrone—Sweating—Thalidomide—leprosy	0.000847	0.00629	CcSEcCtD
Mitoxantrone—Haematuria—Thalidomide—leprosy	0.000843	0.00625	CcSEcCtD
Mitoxantrone—Sinusitis—Thalidomide—leprosy	0.000829	0.00615	CcSEcCtD
Mitoxantrone—Agranulocytosis—Thalidomide—leprosy	0.000825	0.00612	CcSEcCtD
Mitoxantrone—Bradycardia—Thalidomide—leprosy	0.000808	0.00599	CcSEcCtD
Mitoxantrone—SLC47A1—tendon—leprosy	0.000799	0.0295	CbGeAlD
Mitoxantrone—Rhinitis—Thalidomide—leprosy	0.000795	0.0059	CcSEcCtD
Mitoxantrone—Hepatitis—Thalidomide—leprosy	0.000793	0.00589	CcSEcCtD
Mitoxantrone—Pharyngitis—Thalidomide—leprosy	0.000787	0.00584	CcSEcCtD
Mitoxantrone—CYP1B1—skin of body—leprosy	0.000769	0.0284	CbGeAlD
Mitoxantrone—TOP2A—testis—leprosy	0.000724	0.0268	CbGeAlD
Mitoxantrone—Chills—Thalidomide—leprosy	0.000712	0.00528	CcSEcCtD
Mitoxantrone—Arrhythmia—Thalidomide—leprosy	0.000709	0.00526	CcSEcCtD
Mitoxantrone—Alopecia—Thalidomide—leprosy	0.000701	0.0052	CcSEcCtD
Mitoxantrone—Vomiting—Dapsone—leprosy	0.0007	0.0052	CcSEcCtD
Mitoxantrone—Headache—Dapsone—leprosy	0.00069	0.00512	CcSEcCtD
Mitoxantrone—Dysgeusia—Thalidomide—leprosy	0.000676	0.00502	CcSEcCtD
Mitoxantrone—Back pain—Thalidomide—leprosy	0.000668	0.00496	CcSEcCtD
Mitoxantrone—SLC47A1—testis—leprosy	0.000662	0.0244	CbGeAlD
Mitoxantrone—Nausea—Dapsone—leprosy	0.000654	0.00485	CcSEcCtD
Mitoxantrone—Vision blurred—Thalidomide—leprosy	0.000651	0.00483	CcSEcCtD
Mitoxantrone—SLC47A1—nervous system—leprosy	0.000649	0.024	CbGeAlD
Mitoxantrone—Ill-defined disorder—Thalidomide—leprosy	0.000641	0.00476	CcSEcCtD
Mitoxantrone—Anaemia—Thalidomide—leprosy	0.000638	0.00474	CcSEcCtD
Mitoxantrone—Malaise—Thalidomide—leprosy	0.000623	0.00462	CcSEcCtD
Mitoxantrone—Leukopenia—Thalidomide—leprosy	0.000618	0.00459	CcSEcCtD
Mitoxantrone—ABCB1—blood vessel—leprosy	0.00061	0.0225	CbGeAlD
Mitoxantrone—Cough—Thalidomide—leprosy	0.000603	0.00447	CcSEcCtD
Mitoxantrone—Convulsion—Thalidomide—leprosy	0.000598	0.00444	CcSEcCtD
Mitoxantrone—Hypertension—Thalidomide—leprosy	0.000596	0.00443	CcSEcCtD
Mitoxantrone—Myalgia—Thalidomide—leprosy	0.000588	0.00436	CcSEcCtD
Mitoxantrone—Chest pain—Thalidomide—leprosy	0.000588	0.00436	CcSEcCtD
Mitoxantrone—Arthralgia—Thalidomide—leprosy	0.000588	0.00436	CcSEcCtD
Mitoxantrone—Anxiety—Thalidomide—leprosy	0.000586	0.00435	CcSEcCtD
Mitoxantrone—CYP1B1—tendon—leprosy	0.000586	0.0216	CbGeAlD
Mitoxantrone—Discomfort—Thalidomide—leprosy	0.000581	0.00431	CcSEcCtD
Mitoxantrone—Confusional state—Thalidomide—leprosy	0.000568	0.00422	CcSEcCtD
Mitoxantrone—Oedema—Thalidomide—leprosy	0.000564	0.00418	CcSEcCtD
Mitoxantrone—Infection—Thalidomide—leprosy	0.00056	0.00416	CcSEcCtD
Mitoxantrone—Shock—Thalidomide—leprosy	0.000555	0.00412	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Thalidomide—leprosy	0.000552	0.0041	CcSEcCtD
Mitoxantrone—Tachycardia—Thalidomide—leprosy	0.00055	0.00408	CcSEcCtD
Mitoxantrone—Skin disorder—Thalidomide—leprosy	0.000547	0.00406	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Thalidomide—leprosy	0.000545	0.00404	CcSEcCtD
Mitoxantrone—Anorexia—Thalidomide—leprosy	0.000537	0.00399	CcSEcCtD
Mitoxantrone—ABCC1—tendon—leprosy	0.000527	0.0195	CbGeAlD
Mitoxantrone—Hypotension—Thalidomide—leprosy	0.000527	0.00391	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000514	0.00381	CcSEcCtD
Mitoxantrone—Paraesthesia—Thalidomide—leprosy	0.000506	0.00376	CcSEcCtD
Mitoxantrone—Dyspnoea—Thalidomide—leprosy	0.000503	0.00373	CcSEcCtD
Mitoxantrone—Somnolence—Thalidomide—leprosy	0.000501	0.00372	CcSEcCtD
Mitoxantrone—Dyspepsia—Thalidomide—leprosy	0.000496	0.00368	CcSEcCtD
Mitoxantrone—Decreased appetite—Thalidomide—leprosy	0.00049	0.00364	CcSEcCtD
Mitoxantrone—Fatigue—Thalidomide—leprosy	0.000486	0.00361	CcSEcCtD
Mitoxantrone—CYP1B1—testis—leprosy	0.000485	0.0179	CbGeAlD
Mitoxantrone—Pain—Thalidomide—leprosy	0.000482	0.00358	CcSEcCtD
Mitoxantrone—Constipation—Thalidomide—leprosy	0.000482	0.00358	CcSEcCtD
Mitoxantrone—CYP1B1—nervous system—leprosy	0.000476	0.0176	CbGeAlD
Mitoxantrone—Feeling abnormal—Thalidomide—leprosy	0.000464	0.00345	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Thalidomide—leprosy	0.000461	0.00342	CcSEcCtD
Mitoxantrone—Urticaria—Thalidomide—leprosy	0.000448	0.00332	CcSEcCtD
Mitoxantrone—Body temperature increased—Thalidomide—leprosy	0.000446	0.00331	CcSEcCtD
Mitoxantrone—Abdominal pain—Thalidomide—leprosy	0.000446	0.00331	CcSEcCtD
Mitoxantrone—ABCC1—testis—leprosy	0.000436	0.0161	CbGeAlD
Mitoxantrone—Hypersensitivity—Thalidomide—leprosy	0.000415	0.00308	CcSEcCtD
Mitoxantrone—Asthenia—Thalidomide—leprosy	0.000404	0.003	CcSEcCtD
Mitoxantrone—Diarrhoea—Thalidomide—leprosy	0.000386	0.00286	CcSEcCtD
Mitoxantrone—CYP2E1—tendon—leprosy	0.000378	0.0139	CbGeAlD
Mitoxantrone—ABCG2—testis—leprosy	0.000361	0.0133	CbGeAlD
Mitoxantrone—Vomiting—Thalidomide—leprosy	0.000358	0.00266	CcSEcCtD
Mitoxantrone—Rash—Thalidomide—leprosy	0.000355	0.00264	CcSEcCtD
Mitoxantrone—Dermatitis—Thalidomide—leprosy	0.000355	0.00264	CcSEcCtD
Mitoxantrone—Headache—Thalidomide—leprosy	0.000353	0.00262	CcSEcCtD
Mitoxantrone—Nausea—Thalidomide—leprosy	0.000335	0.00249	CcSEcCtD
Mitoxantrone—CYP2E1—testis—leprosy	0.000313	0.0115	CbGeAlD
Mitoxantrone—CYP2E1—nervous system—leprosy	0.000307	0.0113	CbGeAlD
Mitoxantrone—CYP3A4—nervous system—leprosy	0.000247	0.00912	CbGeAlD
Mitoxantrone—ABCB1—testis—leprosy	0.000178	0.00658	CbGeAlD
Mitoxantrone—ABCB1—nervous system—leprosy	0.000175	0.00645	CbGeAlD
